Literature DB >> 22895735

[Rheumatic diseases with initial manifestations in middle age: gout, rheumatoid arthritis and ANCA-associated vasculitides].

S Kleinert1, H P Tony.   

Abstract

Rheumatic diseases are manifested in all ages. First manifestations of gout are frequent between the ages of 40-60 years. Furthermore, the incidence of rheumatoid arthritis increases as well as anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitides. Recently new treatment options for gout were established but colchicine, which has been used to treat gout for a long time was also further optimized in its use. Remarkable advantages in the treatment of rheumatoid arthritis towards remission have been made by the introduction of biological agents 10 years ago. In granulomatosis with polyangiitis (formerly Wegener's disease) therapeutic optimization has led to a reduction in toxicity and rituximab has proven to be an effective treatment option.

Entities:  

Mesh:

Year:  2012        PMID: 22895735     DOI: 10.1007/s00108-012-3030-9

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  17 in total

1.  Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies.

Authors:  L R Lard; H Visser; I Speyer; I E vander Horst-Bruinsma; A H Zwinderman; F C Breedveld; J M Hazes
Journal:  Am J Med       Date:  2001-10-15       Impact factor: 4.965

2.  Clinical manifestations and treatment of Wegener's granulomatosis.

Authors:  Julia U Holle; Martin Laudien; Wolfgang L Gross
Journal:  Rheum Dis Clin North Am       Date:  2010-08       Impact factor: 2.670

3.  2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

Authors:  Daniel Aletaha; Tuhina Neogi; Alan J Silman; Julia Funovits; David T Felson; Clifton O Bingham; Neal S Birnbaum; Gerd R Burmester; Vivian P Bykerk; Marc D Cohen; Bernard Combe; Karen H Costenbader; Maxime Dougados; Paul Emery; Gianfranco Ferraccioli; Johanna M W Hazes; Kathryn Hobbs; Tom W J Huizinga; Arthur Kavanaugh; Jonathan Kay; Tore K Kvien; Timothy Laing; Philip Mease; Henri A Ménard; Larry W Moreland; Raymond L Naden; Theodore Pincus; Josef S Smolen; Ewa Stanislawska-Biernat; Deborah Symmons; Paul P Tak; Katherine S Upchurch; Jirí Vencovsky; Frederick Wolfe; Gillian Hawker
Journal:  Ann Rheum Dis       Date:  2010-09       Impact factor: 19.103

4.  Rituximab versus cyclophosphamide for ANCA-associated vasculitis.

Authors:  John H Stone; Peter A Merkel; Robert Spiera; Philip Seo; Carol A Langford; Gary S Hoffman; Cees G M Kallenberg; E William St Clair; Anthony Turkiewicz; Nadia K Tchao; Lisa Webber; Linna Ding; Lourdes P Sejismundo; Kathleen Mieras; David Weitzenkamp; David Ikle; Vicki Seyfert-Margolis; Mark Mueller; Paul Brunetta; Nancy B Allen; Fernando C Fervenza; Duvuru Geetha; Karina A Keogh; Eugene Y Kissin; Paul A Monach; Tobias Peikert; Coen Stegeman; Steven R Ytterberg; Ulrich Specks
Journal:  N Engl J Med       Date:  2010-07-15       Impact factor: 91.245

5.  Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.

Authors:  Rachel B Jones; Jan Willem Cohen Tervaert; Thomas Hauser; Raashid Luqmani; Matthew D Morgan; Chen Au Peh; Caroline O Savage; Mårten Segelmark; Vladimir Tesar; Pieter van Paassen; Dorothy Walsh; Michael Walsh; Kerstin Westman; David R W Jayne
Journal:  N Engl J Med       Date:  2010-07-15       Impact factor: 91.245

6.  Management of treatment resistant inflammation of acute on chronic tophaceous gout with anakinra.

Authors:  D McGonagle; A L Tan; S Shankaranarayana; J Madden; P Emery; M F McDermott
Journal:  Ann Rheum Dis       Date:  2007-12       Impact factor: 19.103

7.  A diagnostic rule for acute gouty arthritis in primary care without joint fluid analysis.

Authors:  Hein J E M Janssens; Jaap Fransen; Eloy H van de Lisdonk; Piet L C M van Riel; Chris van Weel; Matthijs Janssen
Journal:  Arch Intern Med       Date:  2010-07-12

Review 8.  Plasma exchange in the treatment of Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and renal limited vasculitis.

Authors:  Alina Casian; David Jayne
Journal:  Curr Opin Rheumatol       Date:  2011-01       Impact factor: 5.006

9.  Ultrasonography in gout: a case-control study.

Authors:  Sébastien Ottaviani; Pascal Richette; Anne Allard; Jérémy Ora; Thomas Bardin
Journal:  Clin Exp Rheumatol       Date:  2012-08-29       Impact factor: 4.473

10.  Comparison of oral prednisolone/paracetamol and oral indomethacin/paracetamol combination therapy in the treatment of acute goutlike arthritis: a double-blind, randomized, controlled trial.

Authors:  Chi Yin Man; Ian T F Cheung; Peter A Cameron; Timothy H Rainer
Journal:  Ann Emerg Med       Date:  2007-02-05       Impact factor: 5.721

View more
  1 in total

1.  Comparison of different assays for the detection of anticyclic citrullinated peptide antibodies in patients with rheumatoid arthritis.

Authors:  Lisha Ma; Wensheng Wang; Lisha Li; Ying Chen; Binxuan Chen; Miaoli Shao; Yongjun Cheng; Renfang Zhou
Journal:  Front Immunol       Date:  2022-08-02       Impact factor: 8.786

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.